Zota Health Care Limited (ZOTA.NS)

INR 891.75

(2.58%)

Net Income Summary of Zota Health Care Limited

  • Zota Health Care Limited's latest annual net income in 2023 was -143.47 Million INR , down -148.54% from previous year.
  • Zota Health Care Limited's latest quarterly net income in 2024 Q1 was -127.23 Million INR , down -83.93% from previous quarter.
  • Zota Health Care Limited reported an annual net income of -57.72 Million INR in 2022, down -164.81% from previous year.
  • Zota Health Care Limited reported an annual net income of 89.07 Million INR in 2021, up 4364.05% from previous year.
  • Zota Health Care Limited reported a quarterly net income of -143.47 Million INR for 2023 FY, down -148.54% from previous quarter.
  • Zota Health Care Limited reported a quarterly net income of -69.17 Million INR for 2023 Q4, down -135.42% from previous quarter.

Annual Net Income Chart of Zota Health Care Limited (2023 - 2010)

Historical Annual Net Income of Zota Health Care Limited (2023 - 2010)

Year Net Income Net Income Growth
2023 -143.47 Million INR -148.54%
2022 -57.72 Million INR -164.81%
2021 89.07 Million INR 4364.05%
2020 -2.08 Million INR -107.62%
2019 27.41 Million INR -50.59%
2018 55.48 Million INR -23.66%
2017 72.67 Million INR 31.16%
2016 55.41 Million INR 6.85%
2015 51.85 Million INR 21.72%
2014 42.6 Million INR 36.12%
2013 31.29 Million INR 22.52%
2012 25.54 Million INR 0.0%
2010 19.83 Million INR 0.0%

Peer Net Income Comparison of Zota Health Care Limited

Name Net Income Net Income Difference
Biocon Limited 10.22 Billion INR 101.403%
Blue Jet Healthcare Limited 1.63 Billion INR 108.762%
Concord Biotech Limited 3.08 Billion INR 104.657%
Dishman Carbogen Amcis Limited -1.53 Billion INR 90.65%
Jubilant Ingrevia Limited 1.82 Billion INR 107.845%
Lyka Labs Limited -24.89 Million INR -476.36%
Panacea Biotec Limited -11.73 Million INR -1123.18%
Piramal Pharma Limited 178.2 Million INR 180.516%
SMS Lifesciences India Limited 90.92 Million INR 257.794%
Supriya Lifescience Limited 1.19 Billion INR 112.046%
Syngene International Limited 5.1 Billion INR 102.813%
TAKE Solutions Limited -1.19 Billion INR 88.005%